Page 80 - ITPS-7-2
P. 80
INNOSC Theranostics and
Pharmacological Sciences Youth brain health check and dysregulation
stages of bipolar disorder: A prospective high-risk study. use disorder. Subst Abus. 2022;43(1):260-266.
J Affect Disord. 2012;142(1-3):57-64.
doi: 10.1080/08897077.2021.1941506
doi: 10.1016/j.jad.2012.04.010
187. Coetzee C, Schellekens AFA, Truter I, Meyer A. Effect of
178. Benningfield MM, Riggs P, Stephan SH. The role of schools past pharmacotherapy for attention-deficit/hyperactivity
in substance use prevention and intervention. Child Adolesc disorder on substance use disorder. Eur Addict Res.
Psychiatr Clin N Am. 2015;24(2):291-303. 2023;29(1):9-18.
doi: 10.1016/j.chc.2014.12.004 doi: 10.1159/000526386
179. Hawk KF, Glick RL, Jey AR, et al. Emergency medicine 188. Messinger JC, Suzuki J. Recognizing and reducing the
research priorities for early intervention for substance use impact of trauma of hospitalization: Considerations for
disorders. West J Emerg Med. 2019;20(2):386-392. persons who use drugs. J Addict Med. 2022;16(1):7-9.
doi: 10.5811/westjem.2019.1.39261 doi: 10.1097/ADM.0000000000000840
180. González RA, Vélez-Pastrana MC, Blankers M, et al. Onset 189. Long Y, Pan N, Ji S, et al. Distinct brain structural
and severity of early disruptive behavioral disorders in abnormalities in attention-deficit/hyperactivity disorder
treatment-seeking substance use disorder patients with and substance use disorders: A comparative meta-analysis.
and without attention-deficit/hyperactivity disorder. Eur Transl Psychiatry. 2022;12(1):368.
Addict Res. 2020;26(4-5):211-222. doi: 10.1038/s41398-022-02130-6
doi: 10.1159/000508653 190. Darbinian N, Darbinyan A, Sinard J, et al. Molecular
181. Kim Y, Kim K, Chartier KG, Wike TL, McDonald SE. markers in maternal blood exosomes allow early detection
Adverse childhood experience patterns, major depressive of fetal alcohol spectrum disorders. Int J Mol Sci.
disorder, and substance use disorder in older adults. Aging 2022;24(1):135.
Ment Health. 2021;25(3):484-491. doi: 10.3390/ijms24010135
doi: 10.1080/13607863.2019.1693974 191. Metz VE, Palzes VA, Kline-Simon AH, et al. Substance use
182. Fuller-Thomson E, Lewis DA, Agbeyaka S. Attention- disorders among primary care patients screening positive
deficit/hyperactivity disorder and alcohol and other for unhealthy alcohol use. Fam Pract. 2022;39(2):226-233.
substance use disorders in young adulthood: Findings doi: 10.1093/fampra/cmab171
from a Canadian nationally representative survey. Alcohol
Alcohol. 2022;57(3):385-395. 192. Klein RJ, Gyorda JA, Jacobson NC. Anxiety, depression,
and substance experimentation in childhood. PLoS One.
doi: 10.1093/alcalc/agab048 2022;17(5):e0265239.
183. Winters DE, Brandon-Friedman R, Yepes G, Hinckley JD. doi: 10.1371/journal.pone.0265239
Systematic review and meta-analysis of socio-cognitive
and socio-affective processes association with adolescent 193. Schnabl B, Arteel GE, Stickel F, et al. Liver specific, systemic
substance use. Drug Alcohol Depend. 2021;219:108479. and genetic contributors to alcohol-related liver disease
progression. Leberspezifische, systemische und genetische
doi: 10.1016/j.drugalcdep.2020.108479 Faktoren, die zum Fortschreiten der alkoholbedingten
184. Speed TJ, Hanks L, Turner G, et al. A comparison of Lebererkrankung beitragen. Z Gastroenterol. 2022;60(1):36-44.
cognitive behavioral therapy for insomnia to standard doi: 10.1055/a-1714-9330
of care in an outpatient substance use disorder clinic
embedded within a therapeutic community: A RE-AIM 194. West ML, Sharif S. Cannabis and psychosis. Child Adolesc
framework evaluation. Trials. 2022;23(1):965. Psychiatr Clin N Am. 2023;32(1):69-83.
doi: 10.1186/s13063-022-06885-7 doi: 10.1016/j.chc.2022.07.004
185. Davis JP, Janssen T, Dworkin ER, Dumas TM, Goldbach J, 195. Gainer DM, Wong C, Embree JA, Sardesh N, Amin A,
Monterosso J. Influences of victimization and comorbid Lester N. Effects of telehealth on dropout and retention in
conditions on substance use disorder outcomes in justice- care among treatment-seeking individuals with substance
involved youth: A discrete time survival mixture analysis. use disorder: A retrospective cohort study. Subst Use
Dev Psychopathol. 2020;32(3):1045-1058. Misuse. 2023;58(4):481-490.
doi: 10.1080/10826084.2023.2167496
doi: 10.1017/S0954579419000750
196. Thakral N, Deutsch-Link S, Singal AK. Therapeutic
186. Veseth M, Svendsen TS, Nesvaag S, Moltu C, Davidson L,
Bjornestad J. “And then the rest happened”- A qualitative pipeline in alcohol-associated liver disease. Semin Liver
exploration of the role that meaningful activities play in Dis. 2023;43(1):60-76.
recovery processes for people with a diagnosis of substance doi: 10.1055/s-0042-1759614
Volume 7 Issue 2 (2024) 20 doi: 10.36922/itps.1472

